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Introduction
Chromosome segregation is a complex and dynamic process 
during which paired sister chromatids attached to the micro-
tubules of the mitotic spindle are equally segregated in the two 
daughter cells. To avoid defects in chromosome segregation, 
mitotic exit is delayed until all chromosomes are properly at-
tached to the mitotic spindle by a control mechanism named the 
spindle assembly checkpoint (SAC; Rieder et al., 1994; Rieder 
and Salmon, 1998).
SAC activation requires numerous proteins that localize at 
the kinetochores in early mitotic stages. The main components of 
this surveillance mechanism have fi  rst been identifi  ed in budding 
yeast and include MAD1, MAD2, MAD3 (Li and Murray, 1991), 
BUB 1, BUB3 (Hoyt et al., 1991), and MPS1 (Weiss and Winey, 
1996). In higher organisms, all of these mitotic checkpoint pro-
teins localize at unattached kinetochores during prometaphase. 
In addition, other kinetochore and centromeric proteins such as 
centromere protein A (CENP-A), C, I, F, E, hMIS12, the Ncd80 
complex, the aurora B complex, and the RZZ (Rod, ZW10, 
Zwilch) complex are necessary for recruitment of the SAC and 
are components of the kinetochore structure (Chan et al., 2005; 
Vos et al., 2006). Localization of SAC proteins at kinetochores 
seems to be hierarchical, implying that the recruitment of some 
depends on the prior recruitment of others (Liu et al., 2006). 
In response to unattached kinetochores, the SAC is activated, result-
ing in the inhibition of CDC20, an activator of the multisubunit 
E3 ubiquitin ligase anaphase-promoting complex/cyclosome 
(APC/C) that is responsible for the metaphase→anaphase transi-
tion (Kramer et al., 1998). CDC20 is sequestered together with 
checkpoint proteins in complexes containing MAD2, BUB3, and 
BUBR1, thus preventing APC/C activation and premature mi-
totic exit (Sudakin et al., 2001). When kinetochores are properly 
attached to spindle microtubules, the spindle checkpoint is turned 
off. This allows the APC/C to ubiquitinate mitotic proteins that 
will then be degraded by the proteasome machinery, triggering 
mitotic exit (Alexandru et al., 1999). In higher eukaryotes, SAC 
is required in normal conditions to check whether chromosomes 
are correctly attached to microtubules before anaphase onset 
(Li and Nicklas, 1995; Rieder et al., 1995). Inactivation of SAC 
genes always results in severe chromosome missegregations in 
mammalian cells. In addition, the depletion of SAC proteins in-
hibits the mitotic arrest induced by microtubule-depolymerizing 
drugs (Meraldi et al., 2004).
The PRP4 gene encodes a 150-kD serine-threonine protein 
kinase that has been implicated in the regulation of mRNA splic-
ing in Schizosaccharomyces pombe, and mutations in PRP4 lead 
to the accumulation of pre-mRNAs (Rosenberg et al., 1991). 
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T
he spindle checkpoint delays anaphase onset until 
every chromosome kinetochore has been efﬁ  ciently 
captured by the mitotic spindle microtubules. In this 
study, we report that the human pre–messenger RNA 
pro  cessing 4 (PRP4) protein kinase associates with kineto-
chores during mitosis. PRP4 depletion by RNA interfer-
ence induces mitotic acceleration. Moreover, we frequently 
observe lagging chromatids during anaphase leading to 
aneuploidy. PRP4-depleted cells do not arrest in mitosis 
after nocodazole treatment, indicating a spindle assembly 
checkpoint (SAC) failure. Thus, we ﬁ  nd that PRP4 is nec-
essary for recruitment or maintenance of the checkpoint 
proteins MPS1, MAD1, and MAD2 at the kinetochores. 
Our data clearly identify PRP4 as a previously unrecog-
nized kinetochore component that is necessary to establish 
a functional SAC.
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Figure 1.  PRP4 antibody and localization during mitosis. (A) Western blot showing PRP4 (left) protein levels in control (−) and PRP4 RNAi–treated cells (+) 
with one of the siRNA oligonucleotides used in this study. The treatment depletes PRP4 but not β-tubulin, which was used as a loading control 
(right). (B)   Immunolocalization of the PRP4 protein kinase in mitotic HeLa cells with afﬁ  nity-puriﬁ  ed antibodies. The cells were ﬁ  xed and stained for 
PRP4 (green and middle panels in monocrome), CENP-A (red and left panels in monocrome), and DNA (blue). PRP4 protein displays a granular and 
punctiform cytoplasmic distribution that makes z stacks difﬁ  cult to interpret. For this reason, only single confocal planes are shown. An enlarged view of the 
centro  meric and kinetochore region (boxed areas) is shown on the right. PRP4 colocalization with CENP-A is mainly detected during prometaphase 
(Table S1, available at http://www.jcb.org/cgi/content/full/jcb.200703133/DC1). (C) PRP4 localization (green) was examined alone on chromosomes PRP4 IS REQUIRED FOR SAC • MONTEMBAULT ET AL. 603
However, the Drosophila melanogaster homologue protein 
has also turned up in screens for genes involved in mitosis (Kiger 
et al., 2003), and, in S. pombe, the expression of a dominant 
truncated PRP4 protein reportedly induced mitotic aberrations, 
suggesting a dual PRP4 function in RNA splicing and mitosis 
in this organism (Gross et al., 1997). Therefore, we decided to 
further explore the possible mitotic role of PRP4.
Results and discussion
We raised a polyclonal antibody against the PRP4 protein. 
Western blotting revealed the expected  150-kD protein 
(Fig. 1 A, left; − lane). By immunofl  uorescence experiments, 
the PRP4 protein appeared on fi  xed interphase cells as nuclear 
punctae (Fig. 2 B), which is in agreement with the localiza-
tion previously described (Kojima et al., 2001; Dellaire et al., 
2002). This nuclear signal disappeared in cells transfected 
with PRP4 siRNA (Fig. 2 B, middle; compare top with   bottom)
as well as the protein band by Western blotting (Fig. 1 A, 
+ lane; and Fig. S1, A and B, available at http://www.jcb.org/
cgi/content/full/jcb.200703133/DC1).
The PRP4 protein kinase was previously shown to asso-
ciate with isolated mitotic chromosome arms (Dellaire et al., 
2002). To further reexamine this subcellular localization, divid-
ing HeLa cells were methanol fi  xed and stained for CENP-A 
(as an inner kinetochore marker) and affi  nity-purifi  ed anti-PRP4 
antibodies (Fig. 1 B). During prometaphase, most kinetochores 
(59.7 ± 19.1%; Table S1, available at http://www.jcb.org/cgi/
content/full/jcb.200703133/DC1) stained positive for PRP4. 
During metaphase and anaphase, 27.0 ± 12.8% and 10.9 ± 
7.1% of all kinetochores, respectively, displayed positive PRP4 
labeling, suggesting that PRP4 leaves the kinetochore during 
metaphase. A strong granular signal was also detected in the 
cytoplasm, indicating that only a small fraction of the protein was 
kinetochore associated.
To confi  rm this kinetochore localization and eliminate the 
cytoplasmic PRP4 pool, isolated chromosomes prepared from 
mitotic cells were spread, fi  xed onto glass coverslips, and pro-
cessed for immunofl  uorescence using anti-PRP4 antibodies. 
We found that PRP4 colocalized with BUBR1 at the outer kineto-
chore region (Fig. 1, C and D). Moreover, isolated chromosomes 
prepared from HeLa cells expressing a GFP-tagged PRP4 pro-
tein also showed a clear colocalization with MAD2 at the outer 
kinetochore region (Fig. S1 C).
This kinetochore localization prompted us to investigate 
whether PRP4 was playing a role during mitosis. To do so, we 
tested three siRNA oligonucleotides directed against different 
parts of the PRP4 mRNA. After 2 d of RNAi treatment with any 
of the oligo sets, PRP4 protein levels were reduced by at least 
80% (Fig. S1 B) compared with control-transfected cells.
Cultures subjected to PRP4 siRNA treatment displayed 
reduced mitotic indexes of 3.1 (±0.8) versus 7.2% (±1.1) for 
control cells after 24 h and 2.8 (±0.4) versus 7.1% (±0.3) after 
48 h (n = 3;  1,000 cells). Among the few mitotic PRP4-
  depleted cells, most were apparently in prometaphase and 
anaphase. Well-defi  ned metaphase cells with aligned chromo-
somes were rare and represented only 11.9% of mitotic cells versus 
46.4% in control cells (Table I). In addition, most of the ana-
phase and telophase cells exhibited abnormal fi  gures (22.2 vs. 
1.6% for control cells) and often showed lagging chromatids/
chromosomes in the spindle midzone (Table I and Fig. 2 A). 
21.0% of the PRP4-depleted cells showed residual DNA bridges 
during cytokinesis (Table II). As a consequence of these segre-
gation defects, during interphase and very late cytokinesis, we 
observed a sevenfold increase in the frequency of cells with 
micronuclei (Table II and Fig. 2, A and B). We decided to check 
whether a GFP-tagged PRP4 RNAi-resistant construct (GFP-
PRP4rr) could save the phenotype caused by PRP4 RNAi. GFP 
or GFP-PRP4rr were cotransfected with control or PRP4 siRNAs 
(Fig. 2, C–E). Western blot analyses showed that the endoge-
nous PRP4 protein level was knocked down after RNAi, but the 
tagged protein remained stable (Fig. 2 C). In control RNAi con-
ditions, GFP- or GFP-PRP4rr–positive cells contained  13% of 
micronuclei. In GFP- or GFP-PRP4rr–positive cells after PRP4 
RNAi, this percentage was  35% and  20%, respectively, 
suggesting that the PRP4 RNA–resistant construct was rescuing 
the PRP4 RNAi phenotype (Fig. 2, D and E). Together, these 
data suggest a role for PRP4 during mitosis.
To further characterize chromosome dynamics and the 
timing of mitosis in control and PRP4-depleted cells, we fi  lmed 
HeLa cells expressing an H2B-GFP transgene (Kimura and 
Cook, 2001). In control HeLa H2B-GFP cells (n = 11), chromo-
somes correctly aligned to form a metaphase plate (Fig. 3 A, top; 
panel at 21 s) before anaphase onset (Fig. 3 A, top; panel at 37 s 
[control]; and Video 1, available at http://www.jcb.org/cgi/content/
full/jcb.200703133/DC1). After PRP4 RNAi (n = 12), anaphase 
always started before chromosome alignment (Fig. 3 A, bottom; 
panel at 23 s; and Video 2). Fig. 3 B also shows that all recorded 
PRP4-depleted cells do not congress their chromosomes to the 
metaphase plate and that mitotic exit occurs earlier than control 
cells. Together, these data show that PRP4 is required for chromo-
some congression and segregation but also for mitotic timing.
To confi  rm this acceleration, the time between nuclear 
envelope breakdown (NEBD) and anaphase onset was ana-
lyzed by live cell imaging of HeLa cells. This time was 56.2 ± 
23.1 min (n = 36) in control cells (Fig. S2 B, available at 
http://www.jcb.org/cgi/content/full/jcb.200703133/DC1). In PRP4-
depleted cells, this time was only 43.1 ± 12.9 (n = 43), 46.4 ± 
7.8 (n = 10), and 33.6 ± 8.0 min (n = 36) after transfection 
with the different PRP4 siRNAs (Fig. S2 B). The mitosis peak 
time (Meraldi et al., 2004) was 49 min for the control cells 
and 38, 41, and 31 min for PRP4 knockdown cells (siRNAs 
1–3), confi  rming that mitosis duration was reduced after PRP4 
RNAi (Fig. S2 A).
spreads isolated from mitotic cells (see Materials and methods). DNA is red. (D) PRP4 (green and left panel in monochrome) colocalizes with BUBR1 (red 
and right panel in monochrome) at the outer kinetochore region of isolated mitotic chromosomes. The chromosomes are shown in blue. Bars (B): 10 μm; 
(C and D) 2 μm.JCB • VOLUME 179 • NUMBER 4 • 2007  604
Figure 2.  PRP4 RNAi leads to chromosome segregation defects. (A) Distribution of β-tubulin (green), γ-tubulin (red), and DNA (blue and bottom panels in 
monochrome) during mitosis in control (top) or PRP4 RNAi–treated cells (bottom). The mitotic stages are displayed at the bottom of each panel. 48 h after PRP4 
RNAi treatment (bottom), most mitotic cells display a prometaphase-like morphology. PRP4-depleted cells exhibit lagging chromosomes during anaphase and 
telophase (arrows). Residual DNA bridges are often observed during cytokinesis (arrows). (B) Control (top) and PRP4-depleted cells (bottom) were stained for 
CENP-A (red), PRP4 (green and middle panels in monochrome), and DNA (blue and right panels in monochrome). The PRP4 knockdown cells often contain 
micronuclei (indicated by red triangles), whereas control nuclei are normal. (C) Control or PRP4 siRNA were cotransfected with GFP or GFP-PRP4rr (indicated at 
the bottom). Protein levels were analyzed by Western blotting against PRP4 (top) or γ-tubulin (bottom; as a loading control). PRP4 protein is knockdown (asterisk), 
whereas the GFP-PRP4 protein level remains stable (arrow) after RNAi. (D) PRP4 siRNA was cotransfected with GFP (left) or GFP-PRP4rr (right). GFP is green, PRP4 IS REQUIRED FOR SAC • MONTEMBAULT ET AL. 605
The S. pombe PRP4 gene was previously shown to be 
required for pre-mRNA splicing (Rosenberg et al., 1991; Gross 
et al., 1997). We then checked whether this process was com-
promised after PRP4 RNAi in HeLa cells (see Materials and 
methods and Fig. S3, available at http://www.jcb.org/cgi/content/
full/jcb.200703133/DC1). Pre-mRNA splicing was identical to 
control cells. Thus, the mitotic effect of PRP4 knockdown is un-
likely to be a secondary consequence of general splicing defects.
These defects were similar to those previously observed after 
the depletion of other SAC components such as MAD2 and 
BUBR1: shorter mitosis duration and chromosome segregation 
defects (Meraldi et al., 2004). In addition, MAD2- and BUBR1-
depleted cells do not arrest in mitosis after treatment with no-
codazole, a drug that depolymerizes mitotic spindle microtubules.
To test for a possible role of PRP4 in SAC signaling, we 
monitored mitotic progression by time-lapse video microscopy 
in the presence of 50 ng/ml nocodazole, conditions in which 
SAC is activated. When control cells entered mitosis, they 
rounded and remained blocked in that stage for the duration of 
the experiment ( 5 h; n > 25), indicating a mitotic arrest 
caused by the presence of a functional SAC (Fig. 3 C, top). 
In contrast, when MAD2- or PRP4-depleted cells were challenged 
in the same conditions, the cells rounded and became adherent 
after 102.5 ± 14.9 min (n = 9) and 97.0 ± 12.3 min (n = 10), 
respectively, indicating their return into interphase without 
chromosome segregation (Fig. 3 C, middle and bottom). In ad-
dition, the mitotic index was analyzed in a time course experi-
ment in control, MAD2-, or PRP4-depleted cells in the presence 
of nocodazole (Fig. 3 D). Although the mitotic index increases 
during the experiment in control cells, indicating checkpoint 
activation and mitotic arrest, the mitotic index did not increase 
in MAD2- and PRP4-depleted cells, indicating a SAC failure. 
In parallel, a rescue experiment was performed by coexpression of 
the PRP4 siRNA with GFP or GFP-PRP4rr constructs described 
previously (Fig. 3 E). The mitotic index of PRP4-  depleted cells 
was low in the presence of GFP. In contrast, a full rescue was 
observed in the presence of the GFP-PRP4rr construct, indicat-
ing that the GFP-tagged PRP4 protein was able to complement 
PRP4 depletion.
To investigate how the absence of the PRP4 protein af-
fected the SAC, we examined whether the PRP4 RNAi treat-
ment disturbed the kinetochore localization of several proteins 
involved in the SAC. The CENP-A, aurora B, BUBR1, and Hec1 
proteins were all localized at the kinetochores of prometaphase 
PRP4-depleted cells (Fig. 4; Liu et al., 2006). On the other hand, 
MPS1, MAD1, and MAD2 were not detected at these kineto-
chores, although their protein levels were normal by Western 
blotting (Figs. 4 and S1 A). Therefore, our data indicate that PRP4 
is specifi  cally required for the ordered recruitment/maintenance 
of MPS1, MAD1, and MAD2 at the kinetochore.
The fi  ssion yeast PRP4 homologue gene seems to be 
necessary for pre-mRNA splicing (Gross et al., 1997), but our 
experiments show that this function is not conserved or required 
for cell viability in the human (Fig. S3). Moreover, all of the 
checkpoint proteins analyzed so far by Western blotting proved 
to be expressed at control levels. This indicates that the defects 
observed in this study are direct and are not caused by the dis-
appearance of known checkpoint proteins. In agreement with a 
direct function for PRP4 during the checkpoint, a pool of the 
PRP4 protein localizes at the kinetochores of isolated chromo-
somes, the right place to perform this mitotic function. More-
over, PRP4 has recently been identifi  ed as a component of the 
human mitotic spindle phosphoproteome, which contains kineto-
chore-associated proteins (Nousiainen et al., 2006).
In this study, we found that PRP4 is important for chromo-
some alignment. In addition, several lines of evidence support our 
conclusion that PRP4 belongs to the family of SAC regulatory 
genes. First, after PRP4 depletion, severe chromosome segregation 
defects are observed. Second, the cells do not arrest in mitosis in 
the presence of nocodazole. By themselves, these two criteria 
indicate a requirement of PRP4 for SAC function. This effect 
can be easily explained by the lack of MPS1 recruitment that is 
itself needed for the recruitment of MAD1 and MAD2.
Interestingly, PRP4 also reduces the mitotic duration. 
This places PRP4 in the checkpoint category, including MAD2   
and BUBR1 (components of the soluble mitotic checkpoint 
complex), which are required to maintain a minimal mitosis 
dura  tion (May and Hardwick, 2006). How does PRP4 mediate 
Table I. Quantiﬁ  cation of mitotic defects after 48-h PRP4 RNAi in HeLa cells
RNAi 
treatment
Prophase Prometaphase Metaphase Anaphase Telophase Lagging chromatids 
during 
anaphase/telophase
%% % % % %
Control RNAi 7.8 ± 1.5 28.4 ± 4.6 46.4 ± 3.6 8.8 ± 2.4 7.0 ± 1.4 1.6 ± 1.5
PRP4 RNAi 9.7 ± 5.1 42.9 ± 7.5 11.9 ± 13.2 6.0 ± 2.7 7.3 ± 6.3 22.2 ± 11.6
Quantiﬁ  cation of mitotic defects after 48-h PRP4 RNAi in HeLa cells. Distribution of mitotic cells in the different stages of mitosis: prophase, prometaphase, 
metaphase, anaphase, and telophase. The values indicate the percentage of cells in each phase ± SD. A supplemental class has been added for aberrant mitosis. 
PRP4-depleted cells exhibited abnormal anaphase and telophase ﬁ  gures with lagging chromosomes. Note that the mitotic index is two times lower in PRP4-
depleted cells.
microtubules are red, and DNA is blue (and monochrome in the bottom panels). The red triangles indicate the presence of micronuclei. Note the absence of 
micronuclei in GFP-PRP4rr–transfected cells (right), whereas the green GFP cells (left) contained numerous micronuclei. (E) Histogram showing the percentage ± SEM 
(error bars) of interphase GFP-expressing cells containing micronuclei. The background of the experiment is 13.0 ± 2.4% and 13.4 ± 1.9% for GFP and 
GFP-PRP4rr, respectively. A rescue is obtained after transfection with GFP-PRP4rr (20 ± 1.3%) but not with GFP (34.1 ± 1.8%). Bars, 10 μm.JCB • VOLUME 179 • NUMBER 4 • 2007  606
this additional function? The simplest hypothesis could be 
that PRP4 regulates the cytoplasmic pool of the mitotic check-
point complex. Indeed, even if a fraction of the PRP4 protein 
is localized at the kinetochore region, most of the protein is 
cytoplasmic with a granular and punctiform distribution dur-
ing mitosis. This localization is intriguing compared with those 
of previously characterized checkpoint proteins. Regardless, 
PRP4 appears to be an important gene regulating SAC, and 
further studies will be required to provide additional mechanis-
tic insights into how PRP4 controls checkpoint function and 
mitotic duration.
Materials and methods
Cell culture
HeLa and HeLa stably expressing GFP-tagged H2B (provided by Dr. H. 
Kimura, University Of Kyoto, Kyoto, Japan) cell lines were maintained in DME 
supplemented with 10% FCS and antibiotics (penicillin and streptomycin).
Interference RNA
siRNA oligonucleotides were purchased from Eurogentec. For human PRP4 
RNAi, three different sequences were used: 5′-U  G  C  A  A  G  A  G  C  C  A  A  C  C  A  A-
G  A  A  -3′, 5′-G  C  A  G  G  A  A  U  C  U  U  C  G  U  C  U  G  A  U  -3′, and 5′-U  G  A  U  A  U  G  U  U  U  G-
C  U  G  C  G  U  A  U  -3′. For the rescue experiment, a siRNA with the sequence 
5′-A  G  A  C  C  A  A  C  G  U  A  A  G  A  A  A  G  U  A  -3′ was used. For MAD2 RNAi, the se-
quence used was 5′-U  A  C  G  G  A  C  U  C  A  C  C  U  U  G  C  U  U  G  -3′ (Tang et al., 2004). 
A random siRNA was used as a control. siRNAs were transfected into 
cells using Lipofectamine 2000 (Invitrogen)  according to the manufacturer’s 
instructions. Each experiment was repeated at least three times.
Plasmid constructions
The PRP4 siRNA-resistant construct (GFP-PRP4rr) was generated by PCR 
using the vector pBlueScriptR-PRP4 (IMAGE clone 4821304; GenBank/
EMBL/DDBJ accession no. BC034969) and two primer pairs (mutations and 
restriction sites are underlined) with the following sequences: (A) 5′-T  C  A  G  A  A-
T  T  C  C  C  G  C  C  G  C  G  G  A  G  A  C  C  C  A  G  -3′, (B) 5′-C  C  T  T  T  A  G  C  T  G  G  T  G  T  A  C  CTTTTTG-
CGCTGATCTTCAGG-3′, (C) 5′-CCTGAAGATCAGCGCAAAAAGG  T  A  C  A  C-
C  A  G  C  T  A  A  A  G  G  -3′, and (D) 5′-C  T  T  G  G  A  T  C  C  G  T  T  T  A  A  A  T  T  T  T  T  T  C  C  T  G  G  A  T  G  -3′. 
Two PCRs were performed with the oligonucleotides A/B and C/D. Both 
PCR products were mixed and ampliﬁ  ed with primers A and D. The result-
ing fragment was cloned into pEGPC3 (BD Biosciences) using EcoRI and 
BamHI restriction sites to generate the GFP-PRP4rr construct. The mutations 
were conﬁ  rmed by DNA sequencing. To generate a recombinant histidine-
tagged PRP4(aa 504–688), a partial sequence of human PRP4 was ampli-
ﬁ  ed by PCR from the vector pBlueScriptR-PRP4 using the primers 5′-G  A  A  G-
A  A  T  T  C  T  T  T  A  A  A  G  G  A  A  G  T  C  T  T  T  C  T  G  A  A  -3′ and 5′-T  T  G  C  G  G  C  C  G  C  A  T  T  G  T  A-
A  C  G  T  T  T  A  T  C  T  A  G  G  A  -3′ (restriction sites are underlined). The PCR product 
was cloned into the pET-21a expression vector (EMD) using EcoRI and NotI 
restriction sites.
Production of a recombinant protein PRP4(aa 504–688)-His and 
anti-PRP4 antibody
Competent Escherichia coli BL21 was transformed with pET-21a-PRP4(aa 
508–688) (EMD). The recombinant protein expression was induced with 
1 mM IPTG in cells during 4 h at 25°C. The protein was puriﬁ  ed according 
to the manufacturer’s instructions (QIAGEN), dialyzed overnight in PBS at 
4°C, and used for rabbit immunization.
Live cell imaging and drug treatment
To monitor chromosome dynamics, HeLa cells carrying GFP-tagged H2B 
were observed 48 h after RNAi treatment. We used an inverted ﬂ  uores-
cence video microscope (DMIRB; Leica) with a 63× NA 1.40 objective 
lens equipped with a Xenon lamp (time exposure of 4 ms) and camera 
(CoolSNAP HQ; Roper Scientiﬁ  c). Z series (six planes, 1-μm step, bin × 2) 
were acquired every 1 min.
To investigate the duration of mitosis, HeLa cells transfected with 
control or with each PRP4 siRNA oligonucleotide were ﬁ  lmed on an in-
verted video microscope (time exposure of 10 ms) for 48 h after RNAi 
treatment. Images were acquired every 1 min. Videos were analyzed to 
determine the delay between the NEBD and anaphase onset.
For SAC functional test, control or PRP4-depleted cells were incu-
bated with 50 ng/ml nocodazole 1 h before ﬁ  lming on an inverted video 
microscope with a 20× NA 0.40 objective lens (time exposure of 10 ms). 
One image was acquired every 5 min. Alternatively, control, MAD2, 
or PRP4 siRNA–treated cells were incubated in the presence of no-
codazole, and the mitotic indices were measured at different time points 
(0–10 h). Each experi  ment was repeated at least three times for each 
siRNA (1–3). Images were treated with MetaMorph software (MDS 
Analytic Technologies).
Immunoﬂ  uorescence analyses on ﬁ  xed cells
HeLa cells were grown on glass coverslips and ﬁ  xed using three different 
protocols. To observe the phenotype after RNAi treatments, cells were ﬁ  xed 
for 10 min in 75% methanol, 3.7% formaldehyde, and 0.5× PBS, permea-
bilized for 2 min in PBS containing 0.1% Triton X-100, and washed three 
times during 5 min in PBS.
For kinetochore and centromeric protein localization, cells were 
ﬁ  xed for 30 min in PHEM buffer (60 mM Pipes, 25 mM Hepes, 10 mM 
EGTA, and 8 mM MgCl2) containing 4% PFA and 0.5% Triton X-100 and 
were washed three times during 5 min in PBS. To monitor PRP4 protein local-
ization at the kinetochores, the cells were prepermeabilized for 60 s in PBS 
and 0.1% Triton X-100 and ﬁ  xed for 10 min at −20°C in methanol.
Cells on coverslips were blocked for 1 h in PBS containing 0.1% 
Triton X-100 and 1% BSA (PBSTB) and were incubated for 2 h at RT with the 
primary antibodies in PBSTB. Secondary antibodies were incubated for 
1 h at RT. Between each incubation, coverslips were washed three times 
for 5 min with PBSTB. Coverslips were mounted in Vectashield containing 
DAPI (Vector Laboratories) to stain the DNA. Samples were viewed with 
a ﬂ  uorescent microscope (DMRXA2; Leica) with a 63× NA 1.32 lens 
equipped with standard ﬂ  uorescence ﬁ  lters. The images were acquired 
with a CoolSNAP ES camera using MetaMorph software and prepared as 
single sections or maximum intensity projections before being processed in 
Photoshop 7.0 (version 7.0; Adobe).
Immunoﬂ  uorescence on puriﬁ  ed chromosomes
500 ng/ml nocodazole was added to cultured cells for 2 h. Mitotic control 
cells or cells expressing the GFP-PRP4rr construct were harvested by mitotic 
shake. Culture medium with mitotic cells was recovered and supple-
mented with 75 mM KCl for 30 min at 37°C. Cells were spun onto cover-
slips at 2,000 rpm for 10 min. Coverslips were ﬁ  xed for 15 min in PBS 
containing 4% PFA and were rinsed in PBS and processed for immuno-
ﬂ  uorescence. Staining was viewed with an inverted confocal microscope 
(DM IRE2 SP2; Leica) equipped with a 63× NA 1.4 objective lens using 
the LCS 3D software (Leica).
Antibodies and Western blotting
In this study, we used monoclonal YL1/2 rat antityrosinated tubulin (Chemicon), 
polyclonal rabbit anti-MAD2, mouse monoclonal anti-HA (Covance), mono-
clonal mouse anti-HEC1 (GeneTex), monoclonal mouse anti-MPS1 (Invitrogen), 
Table II. Quantiﬁ  cation of aberrant cells during cytokinesis and interphase after 48-h PRP4 RNAi in HeLa cells
RNAi treatment Cytokinesis Interphase cells
With micronuclei With DNA bridge With micronuclei
%%%
Control RNAi 6.2 ± 1.2 3.0 ± 2.9 3.9 ± 0.8
PRP4 RNAi 44.2 ± 13.9 21.0 ± 5.56 30.9 ± 6.4
Quantiﬁ  cation of aberrant cells in cytokinesis and interphase after PRP4 RNAi. The values indicate the percentage of cytokinesis or interphase cells displaying residual 
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Figure 3.  PRP4 depletion prevents correct chromosome congression and segregation and induces premature anaphase onset and SAC override. (A) HeLa 
cells expressing H2B-GFP were ﬁ  lmed at the onset of mitosis to monitor chromosome dynamics in control (n = 11; top) or PRP4 siRNA–transfected cells 
(n = 12; bottom). Time in hours/minutes is displayed at the bottom right of each panel. The metaphase plate is formed 21 min after NEBD, and anaphase 
onset starts after 37 min in the control (A, top; also see Video 1, available at http://www.jcb.org/cgi/content/full/jcb.200703133/DC1). After PRP4 RNAi, 
anaphase starts 14 min after NEBD, although all chromosomes have not aligned on a metaphase plate, leading to lagging chromosomes. This results in a 
chromatin bridge (23 s and arrows, bottom; also see Video 2). (B) Prophase (green), prometaphase (orange), and metaphase duration (blue) are displayed 
for each control (top) or PRP4 RNAi–treated cell (bottom). The asterisks are indicative of anaphase onset before metaphase plate formation. The histogram 
shows that PRP4-depleted cells fail to congress their chromosomes to the metaphase plate at a time when this event is achieved in the control cells. (C) HeLa 
cells were treated with nocodazole 1 h before ﬁ  lming to trigger microtubule depolymerization and SAC activation. The ﬁ  gure represents selected frames 
of nocodazole-treated HeLa cells transfected with control (top), MAD2 (middle), or PRP4 siRNA (bottom). In control (top), the cell enters mitosis (as judged 
by cell rounding; 15 s) and remains blocked at this stage for the duration of the observation (5 min 15 s), indicating that the SAC is activated. The MAD2- 
(middle) and PRP4 (bottom)-depleted cells enter mitosis (15 s) but return into interphase, as observed by the cell reﬂ  attening (1 min 40 s and 1 min 35 s, 
respectively), indicating a SAC override. The time is displayed (hours/minutes) at the top left of each panel. (D) Control (blue), MAD2- (red), or PRP4 
siRNA–treated cells (green) were incubated in the presence of nocodazole 24 h after siRNA transfection, and the mitotic indices were analyzed at 0, 2, 
4, 6, 8, and 10 h. The values show the mean mitotic indices ± SEM (error bars). Control cells arrest normally in mitosis, unlike MAD2- and PRP4-depleted 
cells, indicating a SAC failure. (E) The PRP4-depleted cells were also cotransfected with GFP or GFP-PRP4rr constructs and treated with nocodazole for 10 h. 
Although depleted cells expressing GFP still show a reduced mitotic index, a full rescue is observed in the presence of the GFP-PRP4rr protein. Bars, 10 μm.JCB • VOLUME 179 • NUMBER 4 • 2007  608
Figure 4.  PRP4 knockdown prevents MPS1, MAD1, and MAD2 recruitment to the kinetochores. Localization of centromeric and kinetochore proteins on 
control (left) or PRP4-depleted cells (right) during prometaphase. Fixed cells are stained from top to bottom for CENP-A, aurora B, BUBR1, Hec1, MPS1, MAD1, 
and MAD2 (shown in monochrome and in red in the merge panels) and are costained for DNA (blue). CENP-A, aurora B, BUBR1, and Hec1 show a normal 
localization, whereas MPS1, MAD1, and MAD2 were absent after PRP4 depletion. Bar, 10 μm.PRP4 IS REQUIRED FOR SAC • MONTEMBAULT ET AL. 609
monoclonal mouse anti–CENP-A and anti-MAD1 (Abcam), monoclonal 
mouse anti-BUBR1 and anti–aurora B (BD Biosciences), monoclonal GTU-88 
mouse anti–γ-tubulin and mouse anti–β-tubulin (clone 2.1) antibodies (Sigma-
Aldrich), and mouse monoclonal anti-MAD2 antibody (Institute of Molecular 
Oncology Foundation). Anti-PRP4 rabbit afﬁ  nity-puriﬁ  ed antibodies were used 
at 1 μg/ml. Secondary FITC, TRITC, and peroxydase-conjugated antibodies 
were purchased from Jackson ImmunoResearch Laboratories.
Western blots were performed according to standard procedures, 
and proteins were visualized using the ECL chemiluminescent reagent 
(Thermo Fisher Scientiﬁ  c). To quantify Western blot protein levels, phosphatase-
conjugated secondary antibodies were used (Jackson ImmunoResearch 
Laboratories) and visualized with the Enhanced ChemiFluorescence reagent 
(GE Healthcare). Quantiﬁ  cation of PRP4 ﬂ  uorescence signal on the nitro-
cellulose membrane was performed using the Storm840 apparatus (Molecular 
Dynamics) with ImageQuant software (GE Healthcare) and β-tubulin as a 
loading control.
Splicing assay
Cells were transfected with the plasmid pAdCMV-glob (Estmer Nilsson et al., 
2001) and/or siRNA using Lipofectamine 2000. After 48 h, cells were 
collected, and total RNA was isolated with the Nucleospin RNA II kit 
(Macherey Nagel) and treated with 4 U Turbo DNase (Ambion). Reverse tran-
scription reactions were performed in the presence of 1 μg of total RNA, 
0.5 μg oligo dT(12–18), and 200 U SuperScript II Reverse Transcriptase 
(Invitrogen) for 50 min at 42°C. PCR reactions were performed with the Expand 
high-ﬁ  delity PCR system (Roche) for 40 cycles. Primers were complemen-
tary to exons 1 and 2 of the β-globin plasmid but not for the endogenous 
β-globin gene. PCR products were separated in agarose gels. If transgenic 
mRNA splicing is effective, a 334-bp PCR product is generated. In case of 
defective mRNA processing, a longer 464-bp product is generated.
Online supplemental material
Fig. S1 shows protein levels in control and PRP4-depleted cells and GFP-PRP4 
kinetochore localization. Fig. S2 presents quantiﬁ  cation of mitosis duration 
in control and PRP4-depleted cells. Fig. S3 shows that human PRP4 knock-
down does not inhibit RNA splicing. Video 1 shows a control mitotic HeLa 
cell expressing GFP-tagged H2B 48 h after control RNAi. Video 2 shows 
a mitotic HeLa cell expressing GFP-tagged H2B 48 h after PRP4 RNAi. 
Table S1 shows the percentages of PRP4-labeled kinetochores during pro-
metaphase, metaphase, and anaphase. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200703133/DC1.
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